JGP Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.66M | Buy |
46,750
+798
| +2% | +$64.4K | 0.33% | 57 |
|
|
2026
Q1 | $3.98M | Sell |
45,952
-28,556
| -38% | -$2.74M | 0.41% | 49 |
|
|
2025
Q4 | $7.16M | Buy |
74,508
+498
| +0.7% | +$48.4K | 0.75% | 37 |
|
|
2025
Q3 | $7.07M | Buy |
74,010
+2,643
| +4% | +$243K | 0.78% | 38 |
|
|
2025
Q2 | $6.22M | Buy |
71,367
+847
| +1% | +$71.8K | 0.75% | 40 |
|
|
2025
Q1 | $6.34M | Sell |
70,520
-77
| -0.1% | -$6.89K | 0.83% | 39 |
|
|
2024
Q4 | $5.64M | Sell |
70,597
-11,604
| -14% | -$1M | 0.73% | 42 |
|
|
2024
Q3 | $7.4M | Buy |
82,201
+2,819
| +4% | +$237K | 0.95% | 42 |
|
|
2024
Q2 | $6.25M | Sell |
79,382
-492
| -0.6% | -$40.3K | 0.89% | 42 |
|
|
2024
Q1 | $6.96M | Buy |
79,874
+1,221
| +2% | +$104K | 1.01% | 44 |
|
|
2023
Q4 | $6.48M | Buy |
78,653
+3,567
| +5% | +$272K | 0.96% | 40 |
|
|
2023
Q3 | $5.88M | Buy |
75,086
+1,874
| +3% | +$157K | 0.99% | 41 |
|
|
2023
Q2 | $6.45M | Buy |
73,212
+4,656
| +7% | +$401K | 1.05% | 39 |
|
|
2023
Q1 | $5.53M | Buy |
68,556
+6,606
| +11% | +$538K | 0.97% | 40 |
|
|
2022
Q4 | $4.81M | Sell |
61,950
-22,698
| -27% | -$1.84M | 0.88% | 42 |
|
|
2022
Q3 | $6.98M | Buy |
84,648
+3,822
| +5% | +$343K | 1.47% | 30 |
|
|
2022
Q2 | $7.24M | Buy |
80,826
+3,803
| +5% | +$385K | 1.46% | 29 |
|
|
2022
Q1 | $8.66M | Buy |
77,023
+4,545
| +6% | +$480K | 1.6% | 26 |
|
|
2021
Q4 | $7.68M | Buy |
72,478
+4,853
| +7% | +$562K | 1.43% | 28 |
|
|
2021
Q3 | $8.48M | Buy |
67,625
+1,151
| +2% | +$149K | 1.83% | 21 |
|
|
2021
Q2 | $8.25M | Buy |
66,474
+4,345
| +7% | +$546K | 1.77% | 23 |
|
|
2021
Q1 | $7.34M | Buy |
62,129
+1,314
| +2% | +$154K | 1.64% | 16 |
|
|
2020
Q4 | $7.12M | Buy |
60,815
+4,388
| +8% | +$483K | 1.65% | 16 |
|
|
2020
Q3 | $5.96M | Buy |
56,427
+3,431
| +6% | +$345K | 1.58% | 19 |
|
|
2020
Q2 | $4.86M | Buy |
52,996
+5,968
| +13% | +$572K | 1.43% | 25 |
|
|
2020
Q1 | $4.67M | Sell |
47,028
-644
| -1% | -$68.5K | 1.65% | 20 |
|
|
2019
Q4 | $5.48M | Buy |
47,672
+4,994
| +12% | +$548K | 1.62% | 21 |
|
|
2019
Q3 | $4.52M | Buy |
42,678
+757
| +2% | +$79K | 1.57% | 22 |
|
|
2019
Q2 | $4.08M | Buy |
41,921
+1,232
| +3% | +$112K | 1.45% | 26 |
|
|
2019
Q1 | $3.71M | Buy |
40,689
+1,382
| +4% | +$124K | 1.4% | 31 |
|
|
2018
Q4 | $3.58M | Buy |
39,307
+764
| +2% | +$71.4K | 1.48% | 21 |
|
|
2018
Q3 | $3.79M | Buy |
38,543
+327
| +0.9% | +$30.2K | 1.52% | 19 |
|
|
2018
Q2 | $3.27M | Buy |
+38,216
| New | +$3.19M | 1.37% | 26 |
|
Other funds holding MDT
FWIA
SRIM
DC
CAI
VF
ETC
JGP Wealth Management's MDT Position: Q2 2026 in Review
JGP Wealth Management increased its Medtronic (MDT) stake by 1.7% in Q2 2026, buying an estimated $64.4K and bringing the position to 46,750 shares worth $3.66M. The position accounts for 0.33% of the portfolio, ranked #57.
JGP Wealth Management first reported a position in MDT in Q2 2018 and has held it in 33 quarters since. The position peaked at $8.66M in Q1 2022. 729 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- JGP Wealth Management held 46,750 shares of Medtronic worth $3.66M as of Q2 2026.
- JGP Wealth Management bought 798 Medtronic shares in Q2 2026, an estimated $64.4K.
- Medtronic made up 0.33% of JGP Wealth Management's portfolio in Q2 2026, its #57 holding.
- JGP Wealth Management first reported a position in Medtronic in Q2 2018 and has held it in 33 quarters since.
- JGP Wealth Management's Medtronic position peaked at $8.66M in Q1 2022.
- 729 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on JGP Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.